Gapping up
In reaction to strong earnings/guidance:
- ARAY +10.8%, SYF +9.4% (also announces extension of strategic partnership with Wal-Mart's (WMT) Sam's Club) EHTH +8.3%, NAVI +7.8%, IBM +7%, CNMD +4.9%, UTX +4.1%, CMCSA +3.3%, PG +3.3%, AMTD +2.6%, TRST +1.9%, FMBI +1.6%, KMB +1.5%, ZION +1.4%, WAT +1.4%
Other news:
- LABL +4.4% (attributed to reports that the company hired advisor to consider sale)
- VIAB +0.1% (confirms plans to acquire Pluto TV, the free streaming television service in U.S., for $340 million in cash)
- ATHX +20.1% (announces summary results from its exploratory clinical study of the intravenous administration of MultiStem cell therapy to treat patients who are suffering from acute respiratory distress syndrome)
- RIGL +13.9% (Rigel Pharma enters into an exclusive license and supply agreement with Grifols)
- NTLA +4.5% (after being down 7% yesterday day)
- AMRN +3.9% (announces acceptance of presentation of new data showing the reduction in total major adverse cardiovascular events shown in the landmark REDUCE-IT cardiovascular outcomes trial as late breaking clinical trial data at the American College of Cardiology's 68th Annual Scientific Session)
- OSTK +1.4% (closed more than 6% lower on the day)
- CEO +0.7% (provides business strategy and development plan for 2019)
Analyst comments:
- TEVA +2.7% (upgraded to Buy from Neutral at UBS)
- LW +1.3% (upgraded to Buy from Hold at Stifel)
- LLY +1.2% (initiated with a Buy at UBS)
- WMT +1.1% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- WY +0.8% (initiated with a Buy at Seaport Global Securities)
